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Background: Hemodialysis patients face numerous physical and psychological stresses that result in reduced
health. The aim of this study is to determine the impact of an empowerment program on self-efficacy, quality of
life, clinical indicators of blood pressure and interdialytic weight gain, and laboratory results in these patients.
Methods: This randomized, controlled trial was conducted at Boo Ali Sina Dialysis Center, Shiraz, Iran. A total of 48
hemodialysis patients participated in this study. After acquisition of informed consent, eligible patients were
randomly divided into two groups, control and experimental. Pre-test data were obtained by using a demographic
data form and two questionnaires for self-efficacy and quality of life. Blood pressure and interdialytic weight gain
were measured. We extracted laboratory data from patients’ charts. A six-week empowerment intervention that
included four individual and two group counselling sessions was performed for the experimental group. Six weeks
after intervention, post-test data were obtained from both groups in the same manner as the pre-test. Data were
analyzed by ANCOVA using SPSS v11.5.
Results: There were no statistically significant differences in demographic variables between the groups. Pre-test
mean scores for self-efficacy, quality of life, blood pressure, interdialytic weight gain and laboratory results did not
differ between the groups. There was a significant difference between the experimental and control groups in
terms of pre-to post-intervention changes in overall self-efficacy scores, stress reduction, and decision making, in
addition to overall quality of life and all dimensions included within quality of life based on this questionnaire.
Additionally, the pre- to post-intervention changes in systolic/diastolic blood pressures, interdialytic weight gain,
hemoglobin and hematocrit levels significantly differed between the groups.
Conclusion: Our study demonstrates that a combination of individual and group empowerment counselling
sessions improves self-efficacy, quality of life, clinical signs, and hemoglobin and hematocrit levels in hemodialysis
patients. Empowerment of hemodialysis patients should be considered in hemodialysis centers to assist patients
with the management of their health-related problems.
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Dialysis lengthens the life of patients with end stage
renal disease (ESRD) [1]. In 2001, it was predicted that
by 2010, the numbers of patients with ESRD would
reach 129,200± 7742 new patients, 651,330± 15874 long-
term ESRD patients, and 520,240± 25609 patients on
hemodialysis (HD) [2]. In 2007, there were 29000 people
in Iran with CRF, of whom 14000 were treated with HD
[3]. HD patients experience many physical and psycho-
logical problems. Zamanzadeh et al. have conducted a cor-
relational study that measured the quality of life (QoL)
and social support of 164 HD patients. The researchers
measured QoL by utilizing a combination of three diffe-
rent questionnaires following validity and reliability ap-
proval. The measurement of social support also included
the combination of an additional three valid, reliable ques-
tionnaires. In this study, the authors have not explained
their rationale for combining different questionnaires to
measure these variables. However they have reported that
over 50% of patients experienced physical and psycho-
logical problems. These aspects of QoL were associated
with social support [4]. Curtin et al., in a cross-sectional
study measured self-management and knowledge in 372
patients from 17 dialysis centers and determined that
patients were low self-managers. The most common self-
management strategies used by patients were the coopera-
tive/participatory activities of self-care during HD and
shared responsibility in care with medical personnel. An-
other important finding of their study was the positive
association between patient knowledge of kidney disease
and treatment to mental health functioning as measured
by the SF-12 Mental Component Summary [5]. In another
study, Sajjadi et al. have highlighted the necessity of con-
stant participation of HD patients in self-care activities to
alleviate problems associated with the illness and its treat-
ment. They conducted a randomized controlled trial with
60 HD patients to elucidate the effects of self-care educa-
tion based on needs assessment on depression. The study
intervention consisted of two, 45 minute self-care educa-
tion programs in addition to an educational booklet for
the experimental group. Patient depression was measured
by a short self-reporting scale. Although this scale is more
appropriate for measurement of depression in the general
population, research has supported the effectiveness of
this self-care education program in reducing depression
amongst HD patients [6].
It appears that there is an increased likelihood for HD
patients to engage in self-management if their self-care
self-efficacy is improved by empowerment programs. An
association has been shown between higher perceived
self-efficacy scores and QoL [7], increased communica-
tion, partnership, self-care, and medication-adherence
behaviors [8]. Empowerment of patients is a model of
intervention used to facilitate decision making and self-care [9]. The components of this model include self-
management education [10], enhancement of goal setting
ability, problem solving, stress management, social sup-
port and motivation [11].
While the empowerment of patients who suffer from
chronic disease such as diabetes have been considered in
different studies [12-15], few studies have been perfor-
med to determine the possible effects of empowerment
in HD patients. Studies on HD patients are mostly de-
scriptive or correlational, highlighting patient behavior
and knowledge [5,8,16] or confirming the correlations
between age, employment status, dialysis modality, and
length of dialysis to knowledge expectations [17]. The
associations between altered QoL to physical and psy-
chiatric co-morbidities, in particular depression and an-
xiety, of patients undergoing chronic HD have been
confirmed in another study [18]. In a systematic review
conducted in 2008 on educational interventions in kid-
ney disease care, promising results were noted for dialy-
sis educational interventions aimed at improving dialysis
and/or fluid concordance, exercise, and coping/adaptation.
Unfortunately many of these studies lacked rigorous eva-
luation [19]. Only one of the reviewed articles in this
systematic review contained the word “empowerment”.
The article of interest was a randomized controlled trial
that researched the effectiveness of an empowerment pro-
gram on empowerment level, self-care self-efficacy and
depression in patients with ESRD. This study randomly
allocated 50 qualified patients to empowerment and con-
trol groups. A problem solving approach was used in the
study’s intervention that included identification of pro-
blems, exploration of emotions, setting goals and appro-
priate strategies to overcome problems, creation and
implementation of behavioral change plans, and stress
management. Findings of this study showed significant
improvements in empowerment, self-care self-efficacy and
depression [20]. In an intervention-evaluation design the
effectiveness of using the empowerment concept during
the development of a mutual-help group for HD was
investigated. The intervention process was conducted in
four phases: (1) assessment, (2) planning, (3) action and
(4) evaluation/feedback. A mutual-help group was formed
that met eight times for group activities over a three-
month study period. Activities such as exchange of ex-
periences, knowledge of self-care, preparation for travel,
educational seminars, social welfare and artistic skills such
as drawing and calligraphy were implemented. The results
showed a significant reduction in physical symptoms and
improvements in social support and QoL [21].
A variety of educational interventions have been
implemented in various studies. Different outcomes are
expected in these studies because of the differences
between the intervention and expected or measured
outcomes that result from the empowerment programs.
Moattari et al. Health and Quality of Life Outcomes 2012, 10:115 Page 3 of 10
http://www.hqlo.com/content/10/1/115This might be due to the fact that empowerment differs
across people, contexts, and times and could be consi-
dered as a nomological network, which includes intra-
personal, interactional, and behavioral components [22].
For example, in one study it was concluded that the in-
ternal locus of control as a component of patient charac-
teristics was positively associated with the mental QoL
component, in particular, the mental health score [18].
Additionally, it is a belief that nurses’ perceptions of
what constitutes quality nursing care may influence their
care of the person receiving HD [23]. Other factors such
as age, disease stages, patient characteristics, co-morbid-
ity, available social supports for patients, as well as back-
ground, attitudes and expertise of nurses make each
nurse-patient relationship a unique experience. Thus,
there is no unified educational prescription for different
patients, or in other words, one size does not fit all.
Empowering HD patients to solve their own problems
and take responsibility for managing their illness and its
associated problems or complications through a problem
solving approach, education and support based on an
individual patient’s needs and shared goal setting can
lower the limitations of providing the same protocol for
all. There is a lack of sufficient literature to support the
effectiveness of empowerment programs on QoL, clinical
and laboratory indicators in HD patients. This is note-
worthy in the context of Iranian culture and particularly
regarding HD patients, thus this study aims to investi-
gate the effect of empowerment on self-care self-efficacy,
QoL, and clinical and laboratory indicators in a group of
Iranian ESRD patients.
Methods
This study was a parallel groups, randomized clinical
trial that assigned eligible patients undergoing HD by
the simple randomization method on a 1:1 ratio to re-
ceive either usual care (control, n = 25) or an empower-
ment program (experimental, n = 25).We approached
potential participants at Boo-Ali Sina Dialysis Center,
Shiraz, Fars Province, Iran, which is the largest dialysis
center in the Middle East over a three month period,
from Nov 2009 to Feb 2010. There was no patient phone
contact, as all enrolled patients were routinely seen at
Boo-Ali Sina Dialysis Center as part of their routine HD.
Eligibility criteria included the following: subjects diag-
nosed with ESRD and treated with HD for at least three
months, ages 18 – 60 years, patients who lived at home,
were able to read and write, had no psychiatric or cogni-
tive disorders, and were willing to participate in the
study. Those with acute illnesses or hospitalized were
excluded.
Patients in the experimental group completed a six-
week empowerment program that consisted of four
individual and two group counselling sessions. Duringindividual counselling patients were assisted with the
development of necessary skills and self-awareness in
goal setting and problem solving. Patients were evaluated
by two different assessment forms, those treated with HD
for three months to less than one year or those treated
with HD for more than one year. The forms were down-
loaded from www.lifeoptions.org and were used to identify
patients’ problem areas for self-management and highlight
their educational needs in ten different aspects that in-
cluded: medical condition, relationship with family and
friends, problems associated with work, school and insur-
ance, eating, future, feelings, responsibilities, life style,
everyday activities, and relationship with staff. Emotions
associated with these problems such as loneliness, feelings
of isolation, hopelessness, fatigue, and suicidal ideation
were explored, and a mutual goal setting approach was
developed to overcome these problems. A written agree-
ment was made between the nurse and patient regarding
the behavior change plan during the intervention with the
intent to increase the likelihood of patients taking the ne-
cessary actions. A behavior change plan was based on the
patient’s priority. Self-efficacy in regards to each behavior
change plan was assessed by a visual analog scale. Patients’
families were involved in the process of empowerment at
the patient’s request. Patients were informed about avai-
lable social support and were referred to the appropriate
centers and experts if necessary. All individual sessions
were conducted by the second author who is qualified to
run these sessions and address HD patients’ problems.
During individual sessions each patient was provided feed-
back regarding their clinical indicators and laboratory
tests.
To run group counselling, the intervention group was
divided into two smaller groups, each attending two ses-
sions for 1.5 - 2 hours. These sessions were conducted
by a psychiatric nurse and focused on stress manage-
ment, problem-focused and emotion-focused coping
strategies, social support and motivation. Group discus-
sion/reflection based on live patients’ experiences, role
playing, and question and answer techniques were used
for making patients aware of their own and others cop-
ing strategies and problem solving techniques. Muscle
relaxation exercise was practiced in the group and a
muscle relaxation audiotape was given to the patients
for stress management. Patients were contacted by phone
to facilitate their continuous involvement in the interven-
tion. The empowerment program was offered only to the
intervention group and the control group received the
usual treatment provided in the setting.
Outcome measures
Primary outcome measures were self-care self-efficacy and
QoL. Secondary outcomes were interdialytic weight gain
(IDWG), blood pressure, and laboratory tests results that
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blood urea nitrogen (BUN), phosphorous (P), calcium
(Ca+), hemoglobin and hematocrit (H&H).
Outcomes were measured prior to treatment (baseline)
and at six weeks post-intervention. We measured self-care
self-efficacy and QoL by the Strategies Used by People to
Promote Health (SUPPH) and QoL questionnaires. Ques-
tionnaires were completed by patients under the supervi-
sion of a nurse who was blinded to treatment allocation.
IDWG and blood pressure were measured by a trained
nurse who was also blinded to the treatment allocation.
Laboratory tests results for Na+, K+, Cr, BUN, P, Ca+, and
H&H were retrieved from the patients’ charts.
Sample size was estimated based on the findings
(d= 25; pooled sd= 30) of another study regarding QoL
[9]. We enrolled 50 patients with the intent to obtain
sufficient statistical power (80%) in detecting differences
between the groups and to predict the study outcomes
between both groups with a significance of p <0.05. In the
post-test, 2 patients failed to continue participation in the
control group; one changed to another dialysis center and
the other patient underwent a kidney transplant. There-
fore data analyses were performed on 48 patients.
Instruments
Demographic data that included age, sex, marital status,
education level, as well as the duration of treatment with
HD and frequency of HD per week were gathered using
a locally designed data form.
Self-care self-efficacy was measured by a 29-item self-
reported questionnaire. The first version of this question-
naire (SUPPH) was developed based on the self-efficacy
theory and includes four dimensions: coping, stress, deci-
sion making, and enjoying life. In another study dimen-
sions of the instrument were reduced to three: positive
attitudes (16 questions), stress (10 questions), and decision
making (3 questions) [24]. The latter questionnaire was
translated into Persian (Farsi) and back-translated into
English to ensure its validity, which was further confirmed
by a panel of experts. Next, the instrument was distributed
to 30 representative patients for measurement of reliabi-
lity. Cronbach’s alpha for the overall questionnaire was
0.91 and for the dimensions of the instrument, it was
as follows: stress reduction (0.79), decision making (0.8),
and positive attitude (0.87). Reliability of the original form
in these dimensions was reported as 0.89 (stress reduc-
tion), 0.83 (decision making), and 0.92 (positive attitude)
[25]. Possible scores for the overall self-care self-efficacy
questionnaire were 29 - 145. The ranges for the dimen-
sions were: positive attitude (16 - 80), stress (10 - 50), and
decision making (3 - 15). Higher scores reflect better
outcomes.
We used the QoL questionnaire that was developed in
1984 by Carol Estwing Ferrans and Marjorie Powers[26]. The instrument consists of two parts. The first part
measures satisfaction with various aspects of life and the
second measures the importance of the same aspects.
Importance ratings are used to weigh the satisfaction
responses. Therefore, the scores reflect the respondents’
satisfaction with the aspects of life as they value. Items
rated as more important have a greater impact on scores
than those of lesser importance. The scores are calcu-
lated both for overall QoL and four subscales of health
and functioning; psychological/spiritual; social and eco-
nomic; and family.
The QoL can be used either as a self-administered ques-
tionnaire or through an interview. If self-administered, the
QoL takes approximately ten minutes to complete. No
special training is required.
The validity and reliability of this questionnaire was
reported by Ferrans and Powers in 1985 and 1992 [27,28].
This questionnaire was translated into Persian by Rambod
and its validity and reliability have been confirmed [3].
The possible range for the final scores is the same
for all four subscales and for the overall (total) score.
Total scores may be classified in three levels: desirable
(score: 20 - 30), relatively desirable (score: 10 - 19) and
unfavorable (score: 0 - 9).
Pre-dialysis blood pressure measurements were taken
using a mercury sphygmomanometer on the non-fistula
arm in accordance with the routine university protocol.
In two consecutive sessions three sitting blood pressure
measurements were taken ten minutes apart, after the
patient had been resting in a quiet room for at least five
minutes. The average of the last two measurements in
two consecutive HD sessions (four readings) was utilized
as the standardized blood pressure for this study.
The amount of weight gain between the end of one
dialysis session and the beginning of the next (IDWG) was
used as a valid marker for adherence to fluid restriction/
regulation. Weight gain was measured in three consecu-
tive HD sessions and the mean was used for analysis.
All patients were registered at the main center in
which the study was conducted and all of their tests
were performed in the same center. This center is
affiliated with the Shiraz University of Medical Scien-
ces (SUMS) and follows the university standards and
protocols.
Ethical considerations
Institutional Review Board (IRB) approval for the stu-
dy was obtained from the Ethics Committee of Shiraz
University of Medical Sciences (ECSUMS). Written
consent was obtained from each patient. The purpose
of study, voluntary participation, confidentiality and
freedom to discontinue at any time without being left
untreated was reviewed with patients prior to their
participation.
Moattari et al. Health and Quality of Life Outcomes 2012, 10:115 Page 5 of 10
http://www.hqlo.com/content/10/1/115Data analysis
Descriptive and inferential statistics that included frequen-
cy, percentage, mean, standard deviation, and ANCOVA
were used by SPSS v11.5. All 25 patients in the treatment
group and 23 out of 25 patients in the control group
were included in the analysis (Figure 1). Self-efficacy
data was analyzed based on its three dimensions.
QoL data was analyzed based on the guideline pro-
vided by Ferrans and Power using the statistical pro-
gram Syntax for SPSS-PC based manual analysis [26].
Based on the guideline, the analysis should be per-
formed through four stages of: recoding satisfaction
scores, weighting satisfaction responses with the pai-
red importance responses, obtaining preliminary sum
for the overall (total) score, and obtaining final over-
all (total) score. The possible range for the final scores is
the same for all four subscales and for the overall (total)
score. Total scores may be classified in three levels: desi-
rable (score: 20 - 30), relatively desirable (score: 10 - 19)
and unfavorable (score: 0 - 9).Results
The results of this study are based on the analyses of 48
out of 50 patients involved in the study (Figure 1).Assessed for e
Analyzed (n=25)
Excluded from analysis (n=0)
Lost to follow-up (n=0)
Allocated to intervention (n=25)






Figure 1 Consolidated Standards of Reporting Trials ( CONSORT) 201Patient characteristics
There were 31 (64.6%) male patients. Patients had a mean
age of 38.16 years, of whom 60.4% were married. Their
education level was as follows: elementary (12.5%), middle
school (39.6%), high school (29.2%) and university edu-
cated (18.7%). The mean duration of HD was 30.16
months [range: 3 - 156 months (13 years)]. HD was admi-
nistered twice weekly in 27.1% of cases and 72.9% received
HD three times a week. Demographic variables for the
study population are shown in Table 1.
Effect of intervention on self-efficacy and quality of life
(QoL)
Adjusted mean scores for self-efficacy and QoL in both
groups and between groups adjusted mean difference are
shown in Table 2. Based on the results of ANCOVA, a sig-
nificant change was observed between the groups in terms
of stress reduction as well as the decision making dimen-
sion and overall self-efficacy scores. Also, a significant dif-
ference was found in the overall mean score of QoL and
in all dimensions of the QoL between the groups.
Effects of intervention on clinical and laboratory data
Results regarding blood pressure, IDWG and laboratory
tests are shown in Table 3. Adjusted mean differencesligibility (n=202)
Excluded  (n=152)
Not meeting inclusion criteria (n=115)
Declined to participate (n=37)
Lost to follow-up:
Relocated to another center (n=1)
Underwent transplantation (n=1)
Allocated to traditional intervention (n=25)







0 Study Flow Diagram.
Table 1 Demographic variables of study population*
Demographic variables Control group Experimental group
Mean age (yrs) at study entry ± SD 37.3 ± 12.79 38.56 ± 11.4
Sex (n = 48) Males (%) 16 (69.6) 15 (60)
Married (%) 15 (65.2 ) 15 (60)
Educational status (%)
Primary school 4 (17.4) 2 (8)
Secondary school 8 (34.8) 11 (44)
Post-secondary school diploma 6 (26.1) 8 (32)
Undergraduate degree 5 (21.7) 4 (16)
Dialysis (%)
Twice per week 5 (21.7) 8 (32)
Three times per week 18 (78.3) 17 (68)
Renal risk markers (%)
Hypertension 7 (30.4) 6 (24)
Diabetes 5 (21.7) 4 (16)
Renal stones 4 (17.4) 0
Infection 1 (4.3) 3 (12)
Other 6 (26.1) 12 (48)
*All comparisons are non-significant. p > 0.05.
Moattari et al. Health and Quality of Life Outcomes 2012, 10:115 Page 6 of 10
http://www.hqlo.com/content/10/1/115between the two groups are significant in both systolic
and diastolic blood pressure and IDWG. No significant
change was found between the groups in their laboratory
results, with the exception of H&H.
Discussion
This study aimed to investigate the effect of empower-
ment on self-care self-efficacy, QoL, and clinical and la-
boratory indicators in a group of ESRD patients. Results
of the study supported the beneficial effects of the inter-
vention on improvements in self-care self-efficacy, QoL,
H&H, stabilizing blood pressure, and lowering IDWG.
Numerous evidences have suggested that the empower-
ment of ESRD patients treated with HD are associated
with outcomes such as improvements in QoL [5,11],
facilitation of decision making, self-care [9], effectiveTable 2 Adjusted mean scores of self-efficacy and QoL in bot
Variables Adjusted mean (SD) Control Experi
Stress reduction 29.94 ± 5.22 33.54 ±
Decision making 7.66 ± 2.01 10.87 ±
Positive attitude 49.12± 7.71 53.21±
Total self-care self-efficacy score 85.78± 11.16 97.8 ± 1
Health and functioning 15.78± 2.97 19.27 ±
Social and economic 16.25± 2.94 19 ± 2.9
Psychological and spiritual 18.76± 3.69 20.94 ±
Family 23.36 ± 4.5 26.41 ±
Total quality of life score 17.54 ± 2.51 20.47 ±management of illness-related problems, and appropri-
ate decision making [10]. These outcomes are somehow
related to the concept of self-efficacy. However, self-
efficacy has been referred to in different ways such as
the goal of an empowerment-based intervention, indica-
tor of empowerment, predisposing factor, and the acqui-
sition of necessary skills for an empowerment process
[29]. In this study, we have defined self-efficacy as the
outcome of an empowerment program. However, in the
current study, two components of self-efficacy (decision
making and stress reduction) improved, whereas no im-
provement in positive attitudes was noted. Improve-
ments in decision making and stress reduction can be
attributed to the features of our empowerment program
such as the provision of individual support for problem
solving and engagement of family members and healthh groups and between groups adjusted mean difference
mental Adjusted mean difference (95%CI) p-value
5.2 −3.6 (-4.4 to -1.57) <0.02
2.05 −3.21 (-4.39 to-2.03) <0.001
7.75 −4.09 (-8.59 to 0.41) >0.073
1.15 −12.02 (-18.41 to -5.53) <0.001
3.00 −3.49 (-5.23 to -1.75) <0.001
5 −2.75 (-4.46 to -1.04) <0.002
3.69 −2.18 (-4.33 to -0.03) <0.047
4.5 −3.05 (-5.66 to -0.420a) <0.024
2.5 −2.93 (-4.39 to -1.47) <0.001
Table 3 Adjusted mean values of clinical and lab indicators in both groups and between groups difference
Indicators Adjusted mean (sd) Adjusted mean difference (95%CI) p-value
Control Experimental
Systolic blood pressure (mm Hg) 143.37± 11.56 129.02± 11.58 14.35 (7.62 to 21.07) <0.001
Diastolic blood pressure (mm Hg) 83.1± 6.08 77.48± 6.08 5.62 (2.08 to 9.16) <0.003
Interdialytic weight gain (kg) 2.52± 0.7 2.08± 0.71 0.44 (0.03 to 0.85) <0.039
Hb (g/dl) 10.98± 2.13 12.97± 2.16 −1.99 (-3.24 to 0.74) <0.005
Hct (%) 33.61± 6.74 40.01± 6.76 −6.4 (-10.33 to -2.47) <0.004
BUN (mg/dL) 42.45± 14.85 39.76± 14.89 2.69 (-5.96 to 11.34) >0.55
Cr (mg/dL) 7.48± 1.84 7.24± 1.87 0.24 (- 0.84 to 1.32) >0.677
Na+ (mEq/L) 138.14± 3.64 136.18± 3.65 1.96 (-0.16 to 4.08) >0.086
K+ (mEq/L) 5.35± 0.9 5.11± 0.91 0.24 (-0.29 to 0.77) >0.393
Ca+ (mg/dL) 8.82± 0.95 9.09± 0.96 −0.27 (-0.83 to 0.29) >0.352
P (mg/dL) 4.53± 1.43 4.77± 1.44 −0.24 (-1.07 to 0.59) >0.59
Hb, Hemoglobin; Hct, Hematocrit; BUN, Blood urea nitrogen; Cr, Creatinine; Na+, Sodium; K+, Potassium; Ca+, Calcium; P, Phosphorous.
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nally, patient participation in the group sessions during
the study intervention and practiced relaxation techni-
ques may be considered as reasons for the observed
changes in stress reduction. Although we have no cri-
teria available to judge the value of the minimally im-
portant difference (MID), but logically even slight
changes in self-efficacy can have tremendous value be-
cause feelings of competency can have greatly impact a
patients’ mental status. This, in turn, can affect their
ability to overcome problems they encounter. Improved
mental status releases expendable energy for problem
solving. In the current study, the observed changes in
decision making, stress reduction and overall self-
efficacy scores are more than half of a SD as a landmark,
which is a previously suggested [30] threshold of dis-
crimination for changes in health-related quality of life
for chronic diseases
Despite the observed change in the positive attitude
score, which was more than what has been suggested
as the minimum important difference (MID) between
groups, [30,31] the difference between our study groups
was not significant. Insignificant changes in positive atti-
tude may be due to the complexity of the problems
encountered by patients, which may require a longer
intervention program. The change in attitude of HD
patients toward their illness seems to be difficult pro-
cesses as patients continually evaluate their condition,
express feelings such as loneliness, isolation, hopeless-
ness, fatigue, and even suicidal ideation. Regardless of
these difficulties, the findings are important and require
us to consider appropriate measures in our empower-
ment programs in future studies.
In the present study, the overall QoL mean score was
relatively desirable which concurred with the findings
of other studies [27,32]. However, several studies havereported low QoL amongst HD patients [33-35]. Walters
and colleagues have concluded in their study that when
dialysis treatment begins for ESRD patients, QoL is
reduced [36].A negative linear correlation between QoL
and duration of HD has been previously shown [32].
Therefore, taking appropriate measures such as education
and patient empowerment has been taken into account in
more depth.
A comparison between the experimental and control
groups revealed a significant difference in overall mean
score of the QoL and all of its dimensions. As previously
mentioned, QoL and the scores of its dimensions can be
categorized in three levels: desirable, relatively desirable,
and unfavorable. In comparing the QoL measures in this
study with what has been suggested for each category it
can be stated that adjusted mean scores of the experi-
mental group in terms of total QoL, as well as the psy-
chological and spiritual, and family dimensions were at
desirable levels. Scores for the other dimensions were
approximately near to desirable. In the control group, all
the QoL adjusted mean scores with the exception of the
family dimension score were at the relatively desirable
level. In a comparison of the lower boundary of confi-
dence interval of total QoL (4.39) with the previously
determined MID (3-4) in another study [37], we were
able to draw a definitive conclusion regarding the treat-
ment effect on QoL. The reason for these clinically and
statistically significant differences between the two
groups could be attributed to empowerment interven-
tion and self-management education that was executed
in the study. Due to their active participation in em-
powerment program, patients learned to take responsi-
bility for solving health-related problems and self-care,
and cooperated in management of their care. We have
considered the cooperation between patients and nur-
sing staff in identifying the patients’ problems as the key
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due to the differences between the health care providers’
and patients’ perceptions of requirements as highlighted
elsewhere [39], this was not an easy process. We should
spend considerable time with patients to reach an agree-
ment on problem identification and its priority, in
addition to the necessary strategies for problem solving,
implementing and evaluation of the action plan.
Of note, the scores of the family dimension compo-
nent of QoL were elevated in both groups both in the
pre- and post-test. This was possibly a result of the cul-
tural context of Iranian families in which family mem-
bers express concern about the patient’s problem and
provide support for their loved one. In a study con-
ducted in Iran, the most desired aspect of social support
was emotional support. The most desired social support
received by the patient was from their family (89%),
while organizational support was the least desired [4].
Ferrans and Powers in a study conducted in a different
culture reported that the QoL family dimension score
was at a desirable level (20 to 30) [27].
The improved QoL score observed in this study was
parallel to the findings of another study that used a
mutual-support group [21]. However, theirs was an
intervention-evaluation design study that did not have a
control group, where all the sessions were conducted in a
group setting. The design of our study was based on a
randomized controlled trial in which the intervention
was based on both individual and group consultations.
Consultation and group intervention have been shown to
improve QoL in HD patients [40,41].
Findings related to blood pressure supported the effec-
tiveness of the empowerment program in maintaining
both systolic and diastolic blood pressures in an accep-
table range. In another study, a significant reduction in
systolic and diastolic blood pressure was shown due to a
diet education program [42]. The significant difference be-
tween the two groups found in our study was more related
to the increase of blood pressure in the control group
(ineffectiveness of conventional program) rather than a
decrease of blood pressure in the experimental group. Of
course, the latter was not expected as the mean pre-test
blood pressure in both groups were about the normal
range for chronic kidney disease patients (<130/80
mmHg) [43], and within the limit (<140/90 mmHg) sug-
gested by the National Kidney Foundation for pre-dialysis
[44]. It seemed that the comprehensive nature of our
newly designed intervention was responsible for enabling
patients (as was evident in their self-efficacy) to maintain
their blood pressure within an acceptable range. It is
believed that an ideal blood pressure in the HD patient
would be associated with hemodynamic stability during
dialysis, orthostatic tolerance after dialysis, better cardio-
vascular survival, and optimal health-related QoL [31].However according to Saint-Remy and Krzesinski, blood
pressure control in HD patients is not an easy task be-
cause extracellular volume modifications during and be-
tween the dialysis sessions can have a considerable and
unpredictable effect on blood pressure [43].
Although measurement of blood pressure was done by
a trained nurse, two points must be considered regar-
ding reliability of the results. First, we measured pre-
dialysis blood pressures, which have been reported to be
biased estimates of systolic and diastolic blood pressure
by a variable amount. Pre-dialysis measurements could
be higher because of increased intravascular volume,
withholding antihypertensive medications immediately
prior to treatment, white coat syndrome, and lack of
standardized measurements [45]. Secondly, the possibi-
lity of overestimation (50 mmHg) or underestimation
(20 mmHg) of blood pressure as stated by Saint-Remy
and Krzesinski existed. These researchers have cautioned
medical professionals about the consideration of blood
pressure measurements in the HD unit as quantitative
and propose that such readings be a qualitative indicator
of control (or lack of control) [43]. Ambulatory blood
pressure monitoring or self-measurement by patients
using home blood pressure monitoring has been sug-
gested in different studies as reflective of a better va-
lidated measure of blood pressure [46,47]. However,
regarding the suggested approaches for blood pressure
control in HD patients, first by slow and smooth re-
moval of extracellular volume (dry weight) and there-
after by appropriate antihypertensive medication [30],
the possible effect of the intervention on medication ad-
herence should not be ignored.
Our study showed that IDWG, as a clinical indicator,
was affected by the empowerment program as the ex-
perimental group had lower IDWG. In a comparison of
the adjusted mean IDWG of both groups to what has
been reported in studies from the US (2.67 ± 1.39) and
Germany (2.28 ± 1.12), [48] we may state that our con-
trol group IDWG was within these ranges, whereas the
IDWG of our experimental group was lower than
observed in the US and German studies, which was re-
flective of the effect of our intervention program. Mea-
sures exist for the correction of water retention between
HD sessions that result in IDWG and edema following
fluid and food intake. These include removal of water
during dialysis either as an isolated treatment (ultrafil-
tration) or in combination with dialysis [49] and lower-
ing dialysate (Na+) concentration [50]. As this was not
the case in our study we attributed our results to the
empowerment program of the study which enabled
patients to enhance their adherence behavior and deci-
sion making in order to overcome the barriers of fluid
intake restriction. In addition, feedback from individual
sessions and awareness about strategies used by other
Moattari et al. Health and Quality of Life Outcomes 2012, 10:115 Page 9 of 10
http://www.hqlo.com/content/10/1/115patients in group sessions could be considered as motiv-
ating factors for patients to monitor their weights. As
the considered minimally important IDWG in this study
falls within the confidence interval, we cannot with
certainty conclude that the empowerment program of
the study was responsible for this change. The effect
of education or motivational interviews on IDWG or
improvement of adherence has been supported by other
studies [43,51].
Analysis of laboratory results (Na+, K+, Cr, BUN, P, Ca+,
and H&H) showed no significant difference between
the two groups, with the exception of H&H which
was significantly higher in the experimental group. That
means the intervention program unintentionally increased
hemoglobin levels, which was not in accordance with
FDA (below 12 g/dl) recommendations [52]. The increase
in H&H can be attributed to the empowerment program
which was mostly based on the individual needs and
approaching problem areas such as eating and life style.
Different studies have reported an association between
higher hemoglobin levels and increased mortality risk due
to cardiovascular disease in both dialysis and non-dialysis
chronic kidney disease patients [53]. However, the noted
increase in the current study was not clinically significant
because patients’ medical conditions were monitored by
their physicians, who likely made some modifications
in their treatment modalities such as erythropoietin-
stimulating agent dose adjustments. Therefore it seemed
that the empowerment program has the potential to lower
the dosage of medication and therefore lower the cost of
treatment. In another study, the beneficial effect of in-
creasing hematocrit on QoL and its safety in selected HD
patients has been reported [54].
Our study demonstrates that a combination of indivi-
dual and group empowerment improves self-efficacy,
QoL, clinical signs, and H&H levels in HD patients. Em-
powerment of HD patients should be considered in HD
centers in order to assist patients with management of
their health-related problems.
Due to the physical, social, psychological and cognitive
complications of HD, nursing intervention based on a
comprehensive approach are required for HD patients.
Patients should be encouraged to actively participate
in self-management of their disease. Empowerment
programs that focus on increasing awareness, know-
ledge, skills, motivation, self-esteem and the creation
of self-efficacy in self-control and preventive behaviors
will lead to increases in self-care self-efficacy, QoL,
and H&H, a decrease in IDWG, and stabilization of
blood pressure. However due to the small sample
size of this study our conclusions are not definitive.
Further studies with a larger sample size and evalua-
tion of the long term effects of such programs are
recommended.Abbreviations
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